VIAN Therapeutics
PrivateLast Round
Seed
Nov 24, 2024
Total Funding Raised
$2.28M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
VIAN Therapeutics operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in November 2024.
VIAN Therapeutics is a biotechnology company developing topical antiangiogenic peptide drugs for the treatment of microvascular retinal diseases such as diabetic retinopathy and age-related macular degeneration.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VIAN Therapeutics Comparables
Compare VIAN Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OcuTerra Therapeutics | 85% | |
| Exonate | 83% | |
| Alephoson Biopharmaceuticals Limited | 77% |
For institutional investors. Book with your work email.
VIAN Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 24, 2024 | ||||
| Seed | Jun 1, 2024 | ||||
| Accelerator | Oct 26, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
VIAN Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BABEL Ventures | Seed |
| IndieBio | Seed, Accelerator |
| Ulu Ventures | Seed |
| SeedFolio | Seed |
| Social Starts | Seed |
| Sand Hill Angels | Seed |
| SOSV | Accelerator, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 78% MoM.
For institutional investors. Book with your work email.
VIAN Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about VIAN Therapeutics's valuation, stock price, and market status.
Is VIAN Therapeutics a public or private company?
VIAN Therapeutics is a private company.
What is the current stock price of VIAN Therapeutics?
VIAN Therapeutics is a private company, so its shares have no public market price. Caplight tracks VIAN Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VIAN Therapeutics worth (valuation)?
Valuation information for VIAN Therapeutics is not publicly available.
Can I buy VIAN Therapeutics stock?
VIAN Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VIAN Therapeutics's last funding round?
VIAN Therapeutics's most recent funding round was Seed on November 24, 2024.
Who are the main investors in VIAN Therapeutics?
Key investors in VIAN Therapeutics include IndieBio.
Will VIAN Therapeutics IPO soon?
No public IPO plans have been announced for VIAN Therapeutics.
How can I track VIAN Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in VIAN Therapeutics's shares on secondary markets.